Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy (Q34480369)

2 August 2017

1 reference

title

Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy (English)

1 reference

human umbilical cord mesenchymal stem cell

2 August 2017

1 reference

Tan Li

1

1 reference

2 August 2017

Mingxu Xia

2

1 reference

2 August 2017

Yuanyuan Gao

3

1 reference

2 August 2017

Yanting Chen

4

1 reference

2 August 2017

Yun Xu

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

12 June 2015

1 reference

Expert Opinion on Biological Therapy

2 August 2017

1 reference

2 August 2017

15

1 reference

2 August 2017

9

1 reference

2 August 2017

1293-1306

1 reference

In vitro hepatic differentiation of human mesenchymal stem cells

2 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Intracellular Ca2+ regulation during neuronal differentiation of murine embryonal carcinoma and mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Mesenchymal progenitor cells in human umbilical cord blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Comparison of mesenchymal stem cells derived from arterial, venous, and Wharton's jelly explants of human umbilical cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Multilineage cells from human adipose tissue: implications for cell-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Nitric oxide-mediated immunosuppressive effect of human amniotic membrane-derived mesenchymal stem cells on the viability and migration of microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Tonsil-derived mesenchymal stem cells alleviate concanavalin A-induced acute liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Comparison of immuno-phenotypes of stem cells from human dental pulp and periodontal ligament

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Skin-derived mesenchymal stem cells help restore function to ovaries in a premature ovarian failure mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Fetal liver-derived mesenchymal stromal cells augment engraftment of transplanted hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Manufacturing and banking of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Mesenchymal stem cells derived from Wharton's Jelly of the umbilical cord: biological properties and emerging clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Mesenchymal cells in the treatment of spinal cord injury: current & future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Isolation and characterisation of mesenchymal stem cells derived from human placenta tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Adipose tissue-derived stem cells in clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Optimization of human umbilical cord mesenchymal stem cell isolation and culture methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton's jelly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

The assessment of cryopreservation conditions for human umbilical cord stroma-derived mesenchymal stem cells towards a potential use for stem cell banking

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Human mesenchymal stem cells - current trends and future prospective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Long-term cryopreservation of human mesenchymal stem cells using carboxylated poly-l-lysine without the addition of proteins or dimethyl sulfoxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

KINETICS OF WATER LOSS FROM CELLS AT SUBZERO TEMPERATURES AND THE LIKELIHOOD OF INTRACELLULAR FREEZING.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Renoprotective effect of human umbilical cord-derived mesenchymal stem cells in immunodeficient mice suffering from acute kidney injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Defining the risks of mesenchymal stromal cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Human umbilical cord Wharton's jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Naïve human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Human Wharton's jelly stem cell conditioned medium and cell-free lysate inhibit human osteosarcoma and mammary carcinoma cell growth in vitro and in xenograft mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Human umbilical cord matrix-derived stem cells expressing interferon-beta gene significantly attenuate bronchioloalveolar carcinoma xenografts in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Cell-based therapy for ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Wharton's jelly-derived cells are a primitive stromal cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Therapeutic effects of hMAPC and hMSC transplantation after stroke in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Feasibility of delivering mesenchymal stem cells via catheter to the proximal end of the lesion artery in patients with stroke in the territory of the middle cerebral artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Multiple cell transplantation based on an intraparenchymal approach for patients with chronic phase stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Functional recovery in acute traumatic spinal cord injury after transplantation of human umbilical cord mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Significant clinical, neuropathological and behavioural recovery from acute spinal cord trauma by transplantation of a well-defined somatic stem cell from human umbilical cord blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Human umbilical cord mesenchymal stem cell therapy on neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Transplantation of umbilical cord and bone marrow-derived mesenchymal stem cells in a patient with relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

The potential of human umbilical cord-derived mesenchymal stem cells as a novel cellular therapy for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Clinical analysis of the treatment of spinocerebellar ataxia and multiple system atrophy-cerebellar type with umbilical cord mesenchymal stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Deficient proliferation of bone marrow-derived mesenchymal stem cells in patients with chronic hepatitis B viral infections and cirrhosis of the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

An In Vivo Model for Monitoring Trans-Differentiation of Bone Marrow Cells into Functional Hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Pilot study of umbilical cord-derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Purkinje cell fusion and binucleate heterokaryon formation in multiple sclerosis cerebellum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Human umbilical mesenchymal stem cells enhance the expression of neurotrophic factors and protect ataxic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Paracrine factors secreted by umbilical cord-derived mesenchymal stem cells induce angiogenesis in vitro by a VEGF-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Human Wharton's jelly mesenchymal stem cells promote skin wound healing through paracrine signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Human mesenchymal stem cells inhibit endothelial proliferation and angiogenesis via cell-cell contact through modulation of the VE-Cadherin/β-catenin signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Comparison of cell proliferation, apoptosis, cellular morphology and ultrastructure between human umbilical cord and placenta-derived mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Adipogenic potential in human mesenchymal stem cells strictly depends on adult or foetal tissue harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Human mesenchymal stromal cells from adult and neonatal sources: a comparative in vitro analysis of their immunosuppressive properties against T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Isolation, expansion and characterisation of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Cryopreservation of umbilical cord mesenchymal cells in xenofree conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

Localization of Mesenchymal Stromal Cells Dictates Their Immune or Proinflammatory Effects in Kidney Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1051528

10.1517/14712598.2015.1051528

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference